UMIN ID: UMIN000017937
Registered date:17/06/2015
WT1 peptide vaccination for patinets with hematological CR after induction chemotherapy
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Cancer vaccine |
| Date of first enrollment | 2015/05/15 |
| Target sample size | 24 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | WT1 peptide + WT1 helper peptide with Montanide WT1 peptide + WT1 helper peptide + CpG with Montanide |
Outcome(s)
| Primary Outcome | Safety of WT1 vaccine therapy before consloidation chemothrapy |
|---|---|
| Secondary Outcome | 2 year DFS or OS |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | 1. double cancer 2. active infections 3. autoinflamatory disease |
Related Information
| Primary Sponsor | Cancer immunotherapy of Osaka University |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | The Ministry of Health Labour and Welfare |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Haruo Sugiyama |
| Address | 2-15 Yamadaoka in Suita city 5650871 |
| Telephone | +81-6-6879-3676 |
| clinical-trial@cit.med.osaka-u.ac.jp | |
| Affiliation | Osaka university Cancer immunotherapy |
| scientific contact | |
| Name | Haruo Sugiyama |
| Address | 2-15 Yamadaoka in Suita city |
| Telephone | +81-6-6879-3676 |
| clinical-trial@cit.med.osaka-u.ac.jp | |
| Affiliation | Osaka university Cancer immunotherapy |